Most people would want to take a blood test that can assess their risk of Alzheimer’s disease, rather than remain anxious about their odds, a new study says.
New anti-amyloid drugs approved to treat Alzheimer’s disease have no clinically meaningful positive effects for patients, a major evidence review has concluded.
